Stockscreener 앱 받기
10.16
2.50%
-0.26
시간 외 거래:
10.17
0.010
+0.10%
전일 마감가:
$10.42
열려 있는:
$10.28
하루 거래량:
625.62K
Relative Volume:
0.73
시가총액:
$976.48M
수익:
-
순이익/손실:
-
주가수익비율:
-18.03
EPS:
-0.5635
순현금흐름:
-
1주 성능:
-0.29%
1개월 성능:
+9.01%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$10.11
$10.70
1주일 범위
$9.545
$10.70
52주 변동 폭
$7.23
$19.45
Lumexa Imaging Holdings Inc Stock (LMRI) Company Profile
명칭
Lumexa Imaging Holdings Inc
전화
704-334-7830
주소
4200 SIX FORKS ROAD, RALEIGH
Compare LMRI vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LMRI
Lumexa Imaging Holdings Inc
|
10.16 | 1.00B | 0 | 0 | 0 | -0.5635 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lumexa Imaging Holdings Inc Stock (LMRI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2026-01-05 | 개시 | Barclays | Overweight |
| 2026-01-05 | 개시 | Deutsche Bank | Buy |
| 2026-01-05 | 개시 | JP Morgan | Overweight |
| 2026-01-05 | 개시 | Jefferies | Buy |
| 2026-01-05 | 개시 | Leerink Partners | Outperform |
| 2026-01-05 | 개시 | Raymond James | Outperform |
| 2026-01-05 | 개시 | Wells Fargo | Overweight |
| 2026-01-05 | 개시 | William Blair | Outperform |
모두보기
Lumexa Imaging Holdings Inc 주식(LMRI)의 최신 뉴스
Top Lumexa Imaging (LMRI) Competitors 2026 - MarketBeat
The reasons Lumexa (LMRI) could be underpriced (Smart Money Outflows) 2026-05-08Sector Rotation - newser.com
Lumexa (LMRI) Q4 earnings miss by steep margin as expenses climb; investors punish stock lightly despite profit shock.Momentum Score - newser.com
The strategic moves Lumexa (LMRI) is making now (Weakens) 2026-05-07Crowd Trend Signals - newser.com
Why Lumexa (LMRI) ability to generate cash matters (+5.65%) 2026-05-06Top Analyst Buy Signals - newser.com
[ARS] Lumexa Imaging Holdings, Inc. SEC Filing - Stock Titan
Board elections, CEO pay detailed in Lumexa Imaging (NASDAQ: LMRI) 2026 proxy - Stock Titan
Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date - The Manila Times
After the close May 12, Lumexa Imaging will post Q1 results - Stock Titan
LMRI Stock Price, Quote & Chart | LUMEXA IMAGING HOLDINGS INC (NASDAQ:LMRI) - ChartMill
LMRI PE Ratio & Valuation, Is LMRI Overvalued - Intellectia AI
Lumexa Imaging names Kyle Lynch as chief growth officer By Investing.com - Investing.com Canada
One of the largest outpatient imaging providers hires a growth chief - Stock Titan
Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer - marketscreener.com
Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer, Effective April 20, 2026 - marketscreener.com
Analysts Have Conflicting Sentiments on These Technology Companies: Lumexa Imaging Holdings, Inc. (LMRI) and Oxford Instruments (OtherOXINF) - The Globe and Mail
Jefferies reiterates Lumexa Imaging stock rating on demand outlook By Investing.com - Investing.com Canada
LMRI Maintains Overweight by Barclays -- Price Target Lowered to $15.00 - GuruFocus
Lumexa Imaging price target lowered to $15 from $23 at Barclays - TipRanks
Analysts’ Top Technology Picks: IonQ (IONQ), Lumexa Imaging Holdings, Inc. (LMRI) - The Globe and Mail
Lumexa Imaging Holdings, Inc. Reiterates 2026 Guidance in 8-K Filing – Company Details, NASDAQ Symbol LMRI, and Key Information - Minichart
Lumexa Imaging reiterates 2026 guidance during site visit By Investing.com - Investing.com Canada
Lumexa Imaging reiterates 2026 guidance during site visit - Investing.com
Lumexa Imaging Holdings IncReiterates full year 2026 guidance on April 8, 2026SEC filing - marketscreener.com
Lumexa Imaging Reaffirms Full-Year 2026 Financial Guidance - TipRanks
Lumexa Imaging reiterates full-year 2026 guidance after site visit - TradingView — Track All Markets
Lumexa Imaging (LMRI) reiterates previously disclosed full-year 2026 guidance - Stock Titan
Should I buy Lumexa Imaging Holdings, Inc. (LMRI) - Zacks Investment Research
Lumexa Imaging Holdings, Inc. Common Stock Stock Forecast Summary - Meyka
Is Lumexa (LMRI) Stock a Top Performer | Price at $9.02, Up 0.89%Community Buy Signals - newser.com
Lumexa Imaging Earnings Call Highlights Growth Momentum - TipRanks
Earnings Call Summary | Lumexa Imaging(LMRI.US) Q4 2025 Earnings Conference - 富途牛牛
Maintaining Buy on LMRI: Market Overdiscounts Consolidated Centers, Creating Upside to $17 Target - TipRanks
Raymond James cuts Lumexa Imaging stock price target on soft outlook - Investing.com Canada
Lumexa Imaging price target lowered to $17 from $23 at Raymond James - TipRanks
Jefferies reiterates Lumexa Imaging stock rating citing growth outlook By Investing.com - Investing.com Canada
LMRI SEC FilingsLumexa Imaging Holdings 10-K, 10-Q, 8-K Forms - Stock Titan
Lumexa Imaging (NASDAQ: LMRI) hits $1.023B revenue and raises $427M IPO - Stock Titan
Lumexa Imaging: Clearer Growth Path Ahead (NASDAQ:LMRI) - Seeking Alpha
LMRI Technical Analysis & Stock Price Forecast - Intellectia AI
Analysts Offer Insights on Technology Companies: Intuit (INTU), Rubrik, Inc. Class A (RBRK) and Lumexa Imaging Holdings, Inc. (LMRI) - theglobeandmail.com
Analysts Offer Insights on Technology Companies: Lumexa Imaging Holdings, Inc. (LMRI), Adobe (ADBE) and Blaize Holdings (BZAI) - The Globe and Mail
Lumexa Imaging Reports Strong Q4 and Full Year 2025 Results, Reiterates 2026 Guidance and Outlines Growth Strategy - Minichart
Lumexa Imaging Posts Strong Q4 Growth, Reaffirms 2026 Outlook - TipRanks
Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged - GlobeNewswire
Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewswire Inc.
Earnings call transcript: Lumexa Imaging Q4 2025 reveals unexpected EPS miss - Investing.com Canada
Lumexa Imaging Holdings Inc (LMRI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.34%
자본화:
|
볼륨(24시간):